Vitamin B12 offers neuronal cell protection by inhibiting Aβ-42 amyloid fibrillation

International Journal of Biological Macromolecules

Volumn 99, Issue , 2017, Pages 477-482

  Alam, Parvez ^a   Siddiqi, Mohammad Khursheed ^a   Chaturvedi, Sumit Kumar ^a   Zaman, Masihuz ^a   Khan, Rizwan Hasan ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Amyloids; Cytotoxicity; Neurodegenation; Protein aggregation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CYANOCOBALAMIN; THIOFLAVINE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ARTICLE; CELL VIABILITY ASSAY; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; PHOTON CORRELATION SPECTROSCOPY; PROTEIN AGGREGATION; PROTEIN MISFOLDING; TRANSMISSION ELECTRON MICROSCOPY; CELL PROTECTION; CHEMICAL PHENOMENA; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; KINETICS; NERVE CELL; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CYTOPROTECTION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; VITAMIN B 12;

EID: 85014811900     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2017.03.001     Document Type: Article

References (41)

1. [1] Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
2. [2] Hamley, I.W., The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Chem. Rev. 112 (2012), 5147–5192.
3. [3] Siddiqi, M.K., Alam, P., Chaturvedi, S.K., Shahein, Y.E., Khan, R.H., Mechanisms of protein aggregation and inhibition. Front. Bio Elite 9 (2016), 1–20.
4. [4] Okamura, N., Furumoto, S., Fodero-Tavoletti, M.T., Mulligan, R.S., Harada, R., Yates, P., Pejoska, S., Kudo, Y., Masters, C.L., Yanai, K., Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain, 2014, awu064.
5. [5] Jakob-Roetne, R., Jacobsen, H., Alzheimer's disease: from pathology to therapeutic approaches. Angew. Chem. Int. Ed. 48 (2009), 3030–3059.
6. [6] Selkoe, D.J., The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8 (1998), 447–453.
7. [7] Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A., Frosch, M.P., Eckman, C.B., Tanzi, R.E., Selkoe, D.J., Guenette, S., Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. 100 (2003), 4162–4167.
8. [8] Bieschke, J., Herbst, M., Wiglenda, T., Friedrich, R.P., Boeddrich, A., Schiele, F., Kleckers, D., del Amo, J.M.L., Gruning, B.A., Wang, Q., Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. Nat. Chem. Biol. 8 (2011), 93–101.
9. [9] Pryor, N.E., Moss, M.A., Hestekin, C.N., Unraveling the early events of amyloid β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size. Int. J. Mol. Sci. 13 (2012), 3038–3072.
10. [10] DaSilva, K.A., Shaw, J.E., McLaurin, J., Amyloid- β fibrillogenesis: structural insight and therapeutic intervention. Exp. Neurol. 223 (2010), 311–321.
11. [11] Meisl, G., Yang, X., Hellstrand, E., Frohm, B., Kirkegaard, J.B., Cohen, S.I.A., Dobson, C.M., Linse, S., Knowles, T.P.J., Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides. Proc. Natl. Acad. Sci. 111 (2014), 9384–9389.
12. [12] Perna, A.F., Ingrosso, D., De Santo, N.G., Homocysteine and oxidative stress. Amino Acids 25 (2003), 409–417.
13. [13] Chaturvedi, S.K., Alam, P., Khan, J.M., Siddiqui, M.K., Kalaiarasan, P., Subbarao, N., Ahmad, Z., Khan, R.H., Biophysical insight into the anti-amyloidogenic behavior of taurine. Int. J. Biol. Macromol. 80 (2015), 375–384.
14. [14] Edward, J.T., Molecular volumes and the Stokes-Einstein equation. J. Chem. Educ., 47, 1970, 261.
15. [15] Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S.A., Krishna, V., Grover, R.K., Roy, R., Singh, S., Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 151 (2005), 229–238.
16. [16] Picken, M.M., Herrera, G.A., Thioflavin, T., Stain: An Easier and More Sensitive Method for Amyloid Detection, Amyloid and Related Disorders. 2017, Springer, 2015, 225–227.
17. [17] Chaturvedi, S.K., Siddiqi, M.K., Alam, P., Khan, R.H., Protein misfolding and aggregation: Mechanism, factors and detection. Process Biochem., 2016.
18. [18] Chaturvedi, S.K., Khan, J.M., Siddiqi, M.K., Alam, P., Khan, R.H., Comparative insight into surfactants mediated amyloidogenesis of lysozyme. Int. J. Biol. Macromol. 83 (2016), 315–325.
19. [19] Siddiqi, M.K., Shahein, Y.E., Hussein, N., Khan, R.H., Effect of surfactants on Ra-sHSPI-A small heat shock protein from the cattle tick Rhipicephalus annulatus. J. Mol. Struct. 1119 (2016), 12–17.
20. [20] Bartolini, M., Bertucci, C., Bolognesi, M.L., Cavalli, A., Melchiorre, C., Andrisano, V., Insight into the kinetic of amyloid beta (amyloid beta- 42) peptide self-aggregation: elucidation of inhibitors mechanism of action. Chembiochem 8 (2007), 2152–2161.
21. [21] Jayamani, J., Shanmugam, G., Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Eur. J. Med. Chem. 85 (2014), 352–358.
22. [22] Sivalingam, V., Patel, B.K., Familial mutations in fibrinogen Aα(FGA) chain identified in renal amyloidosis increase in vitro amyloidogenicity of FGA fragment. Biochimie 127 (2016), 44–49.
23. [23] Plakoutsi, G., Taddei, N., Stefani, M., Chiti, F., Aggregation of the acylphosphatase from sulfolobus solfataricus THE FOLDED AND PARTIALLY UNFOLDED STATES CAN BOTH BE PRECURSORS FOR AMYLOID FORMATION. J. Biol. Chem. 279 (2004), 14111–14119.
24. [24] Siddiqi, M.K., Alam, P., Chaturvedi, S.K., Nusrat, S., Shahein, Y.E., Khan, R.H., Attenuation of amyloid fibrillation in presence of Warfarin: a biophysical investigation. Int. J. Biol. Macromol. 95 (2017), 713–718.
25. [25] Ramshini, H., Mannini, B., Khodayari, K., Ebrahim-Habibi, A., Moghaddasi, A.S., Tayebee, R., Chiti, F., Bis (indolyl) phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme. Eur. J. Med. Chem. 124 (2016), 361–371.
26. [26] Greenfield, N.J., U sing circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1 (2006), 2876–2890.
27. [27] Fasman, G.D., Circular Dichroism and the Conformational Analysis of Biomolecules. 2013, Springer Science & Business Media.
28. [28] Chaturvedi, S.K., Zaidi, N., Alam, P., Khan, J.M., Qadeer, A., Siddique, I.A., Asmat, S., Zaidi, Y., Khan, R.H., Unraveling comparative anti-Amyloidogenic behavior of pyrazinamide and D-cycloserine: a mechanistic biophysical insight. PLoS One, 10, 2015, e0136528.
29. 2-sheet transition and the early stage of aggregation of the Aβ (12–28) fragment from the Alzheimer peptide. J. Am. Chem. Soc. 122 (2000), 4261–4268.
30. [30] Alam, P., Chaturvedi, S.K., Siddiqi, M.K., Rajpoot, R.K., Ajmal, M.R., Zaman, M., Khan, R.H., Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases. Sci. Rep., 6, 2016.
31. [31] Rosen, L.E., Connell, K.B., Marqusee, S., Evidence for close side-chain packing in an early protein folding intermediate previously assumed to be a molten globule. Proc. Natl. Acad. Sci. 111 (2014), 14746–14751.
32. [32] Siddiqi, M.K., Alam, P., Chaturvedi, S.K., Khan, R.H., Anti-amyloidogenic behavior and interaction of diallylsulfide with human serum albumin. Int. J. Biol. Macromol. 92 (2016), 1220–1228.
33. [33] Abdelhameed, A.S., Alam, P., Khan, R.H., Binding of janus kinase inhibitor tofacitinib with human serum albumin: multi-technique approach. J. Biomol. Struct. Dyn. 34 (2017), 2037–2044.
34. [34] Gong, H., He, Z., Peng, A., Zhang, X., Cheng, B., Sun, Y., Zheng, L., Huang, K., Effects of several quinones on insulin aggregation. Sci. Rep., 4, 2014, 5648.
35. [35] Scheibel, T., Parthasarathy, R., Sawicki, G., Lin, X.-M., Jaeger, H., Lindquist, S.L., Conducting nanowires built by controlled self-assembly of amyloid fibers and selective metal deposition. Proc. Natl. Acad. Sci. 100 (2003), 4527–4532.
36. [36] Ghosh, A., Pradhan, N., Bera, S., Datta, A., Krishnamoorthy, J., Jana, N.R., Bhunia, A., Inhibition and degradation of amyloid beta (amyloid beta- 40) fibrillation by designed small pep-tide: a combined spectroscopy, microscopy and cell toxicity study. ACS Chem. Neurosci., 2017, 10.1021/acschemneuro.6b00349.
37. [37] Thapa, A., Jett, S.D., Chi, E.Y., Curcumin attenuates amyloid-β aggregate toxicity and modulates amyloid-β aggregation pathway. ACS Chem. Neurosci. 7 (2015), 56–68.
38. [38] Xiao, L., Zhao, D., Chan, W.-H., Choi, M.M.F., Li, H.-W., Inhibition of beta amyloid beta- 40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots. Biomaterials 31 (2010), 91–98.
39. [39] Howlett, D.R., Jennings, K.H., Lee, D.C., Clark, M.S.G., Brown, F., Wetzel, R., Wood, S.J., Camilleri, P., Roberts, G.W., Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4 (1995), 23–32.
40. [40] Bieschke, J., Russ, J., Friedrich, R.P., Ehrnhoefer, D.E., Wobst, H., Neugebauer, K., Wanker, E.E., EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. 107 (2010), 7710–7715.
41. [41] Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C.M., Cecchi, C., A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol., 6, 2010, 140.